Patents by Inventor Adam Watkinson

Adam Watkinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD AND COMPOSITION FOR TRANSDERMAL DRUG DELIVERY
    Publication number: 20160250227
    Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.
    Type: Application
    Filed: October 6, 2015
    Publication date: September 1, 2016
    Applicant: Acrux DDS Pty Ltd
    Inventors: Tony DIPIETRO, Andrew HUMBERSTONE, Igor GONDA, Adam WATKINSON, Kerrie SETIAWAN, Nina WILKINS
  • TRANSDERMAL DELIVERY SYSTEM
    Publication number: 20160022820
    Abstract: A transdermal delivery system comprising a composition comprising a physiologically active agent and a penetration enhancer wherein the penetration enhancer comprises a combination of (i) an ester of salicylic acid, preferably selected from the C6 to C30 aliphatic ester of salicylic acid and (ii) polyethylene glycol (PEG) of average molecular weight no more than 300.
    Type: Application
    Filed: June 10, 2015
    Publication date: January 28, 2016
    Applicant: Acrux DDS Pty Ltd.
    Inventors: Kerrie Setiawan, Adam Watkinson
  • Method and composition for transdermal drug delivery
    Patent number: 9180194
    Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.
    Type: Grant
    Filed: October 8, 2014
    Date of Patent: November 10, 2015
    Assignee: ACRUX DDS PTY LTD
    Inventors: Tony Dipietro, Andrew Humberstone, Igor Gonda, Adam Watkinson, Kerrie Setiawan, Nina Wilkins
  • Transdermal delivery system
    Patent number: 9078810
    Abstract: A transdermal delivery system comprising a composition comprising a physiologically active agent and a penetration enhancer wherein the penetration enhancer comprises a combination of (i) an ester of salicylic acid, preferably selected from the C6 to C30 aliphatic ester of salicylic acid and (ii) polyethylene glycol (PEG) of average molecular weight no more than 300.
    Type: Grant
    Filed: May 6, 2013
    Date of Patent: July 14, 2015
    Assignee: ACRUX DDS PTY LTD
    Inventors: Kerrie Setiawan, Adam Watkinson
  • Method and composition for transdermal drug delivery
    Patent number: 8993520
    Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.
    Type: Grant
    Filed: June 25, 2010
    Date of Patent: March 31, 2015
    Assignee: Acrux DDS Pty Ltd
    Inventors: Tony Dipietro, Andrew Humberstone, Igor Gonda, Adam Watkinson, Kerrie Setiawan, Nina Wilkins
  • METHOD AND COMPOSITION FOR TRANSDERMAL DRUG DELIVERY
    Publication number: 20150087623
    Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.
    Type: Application
    Filed: October 8, 2014
    Publication date: March 26, 2015
    Applicant: Acrux DDS Pty Ltd
    Inventors: Tony DIPIETRO, Andrew HUMBERSTONE, Igor GONDA, Adam WATKINSON, Kerrie SETIAWAN, Nina WILKINS
  • TRANSDERMAL DELIVERY SYSTEM FOR HORMONES AND STEROIDS
    Publication number: 20130317462
    Abstract: A transdermal delivery system comprising a composition comprising a pharmacological agent and a penetration enhancer wherein the penetration enhancer comprises polyethylene glycol (PEG) of average molecular weight no more than 300.
    Type: Application
    Filed: May 6, 2013
    Publication date: November 28, 2013
    Applicant: Acrux DDS Pty Ltd.
    Inventors: Kerrie Setiawan, Adam Watkinson
  • TRANSDERMAL DELIVERY SYSTEM
    Publication number: 20130317122
    Abstract: A transdermal delivery system comprising a composition comprising a physiologically active agent and a penetration enhancer wherein the penetration enhancer comprises a combination of (i) an ester of salicylic acid, preferably selected from the C6 to C30 aliphatic ester of salicylic acid and (ii) polyethylene glycol (PEG) of average molecular weight no more than 300.
    Type: Application
    Filed: May 6, 2013
    Publication date: November 28, 2013
    Applicant: Acrux DDs Pty Ltd.
    Inventors: Kerrie Setiawan, Adam Watkinson
  • Method and composition for transdermal drug delivery
    Patent number: 8435944
    Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.
    Type: Grant
    Filed: June 2, 2006
    Date of Patent: May 7, 2013
    Assignee: Acrux DDS Pty Ltd.
    Inventors: Tony Dipietro, Andrew Humberstone, Igor Gonda, Adam Watkinson, Kerrie Setiawan, Nina Wilkins
  • METHOD AND COMPOSITION FOR TRANSDERMAL DRUG DELIVERY
    Publication number: 20100322884
    Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.
    Type: Application
    Filed: June 25, 2010
    Publication date: December 23, 2010
    Inventors: Tony DiPietro, Andrew Humberstone, Igor Gonda, Adam Watkinson, Monique Robinson, Kerrie Setiawan, Carolyn Stone, Nina Wilkins
  • TRANSDERMAL DELIVERY SYSTEM
    Publication number: 20100297032
    Abstract: A transdermal delivery system comprising a composition comprising a physiologically active agent and a penetration enhancer wherein the penetration enhancer comprises a combination of (i) an ester of salicylic acid, preferably selected from the C6 to C30 aliphatic ester of salicylic acid and (ii) polyethylene glycol (PEG) of average molecular weight no more than 300.
    Type: Application
    Filed: October 31, 2008
    Publication date: November 25, 2010
    Inventors: Kerrie Setiawan, Adam Watkinson
  • TRANSDERMAL DELIVERY SYSTEM FOR HORMONES AND STEROIDS
    Publication number: 20100279988
    Abstract: A transdermal delivery system comprising a composition comprising a pharmacological agent and a penetration enhancer wherein the penetration enhancer comprises polyethylene glycol (PEG) of average molecular weight no more than 300.
    Type: Application
    Filed: October 31, 2008
    Publication date: November 4, 2010
    Inventors: Kerrie Setiawan, Adam Watkinson
  • Method and composition for transdermal drug delivery
    Publication number: 20060280783
    Abstract: The invention is directed to a transdermal drug delivery composition which includes at least one physiologically active agent; and at least one volatile solvent; and at least one viscosity modulating agent. The invention extends to methods of administering such a composition to a subject and treatment of subjects using the composition.
    Type: Application
    Filed: June 2, 2006
    Publication date: December 14, 2006
    Inventors: Tony Dipietro, Andrew Humberstone, Igor Gonda, Adam Watkinson, Monique Robinson, Kerrie Setiawan, Carolyn Stone, Nina Wilkins
  • Transdermal granisetron
    Publication number: 20060177493
    Abstract: Adhesive patches for the transdermal administration of granisetron, comprise an acrylic adhesive containing non-acidic nucleophilic moieties which substantially increase flux of granisetron across the skin.
    Type: Application
    Filed: February 5, 2004
    Publication date: August 10, 2006
    Applicant: Strakan Limited
    Inventors: Peter Altenschopfer, Adam Watkinson